<DOC>
	<DOCNO>NCT00528697</DOCNO>
	<brief_summary>The purpose study test investigational medication ABT-089 safe effective treatment child Attention-Deficit/Hyperactivity Disorder ADHD .</brief_summary>
	<brief_title>A Safety Efficacy Study ABT-089 Children With Attention-Deficit/Hyperactivity Disorder ( ADHD )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Have voluntarily sign informed consent form Meet diagnostic criterion attentiondeficit/hyperactivity disorder ( ADHD ) base detailed evaluation interview parent ( ) First grade high school set 3 days/week Subject generally good health base medical history , physical examination , clinical lab test , ECG Subject weigh least 37 pound ( 17 kg ) Female subject childbearing potential must negative urine pregnancy test screening baseline agree comply applicable contraceptive requirement Subject parent judge study doctor reliable keep require appointment clinic visit test , include blood draw , examination Subject function ageappropriate level intellectually Subject current past diagnosis bipolar disorder , psychosis , autism , Asperger 's syndrome , pervasive developmental disorder Current diagnosis obsessivecompulsive disorder , eat disorder , anxiety disorder depressive disorder require treatment kind Subject history significant allergic reaction drug Subject require ongoing treatment psychiatric medication Subject serious medical condition , seizure disorder ( except febrile seizure infant ) , history substance abuse dependence</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>